🐢
|
Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain
23 auth.
J. Rello,
Alejandro Rodríguez,
P. Ibáñez,
L. Socias,
J. Cebrián,
Asunción Marqués,
J. Guerrero,
S. Ruiz-Santana,
E. Márquez,
F. del Nogal-Sáez,
...
F. Álvarez-lerma,
S. Martínez,
M. Ferrer,
M. Avellanas,
R. Granada,
E. Maraví-Poma,
P. Albert,
R. Sierra,
L. Vidaur,
Patricia Ortiz,
I. Prieto del Portillo,
B. Galván,
C. León-Gil
|
8 |
2009 |
8 🐢
|
🐜
|
Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy
8 auth.
J. Nolla-Salas,
A. Sitges-Serra,
C. León-Gil,
J. Martínez-González,
M. A. León-Regidor,
P. Ibán˜ez-Lucía,
...
J. M. Torres-Rodríguez,
Study Group of Fungal Infection in the Icu
|
8 |
1997 |
8 🐜
|
🐜
|
Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM)
18 auth.
A. Rhodes,
R. Moreno,
É. Azoulay,
M. Capuzzo,
J. Chiche,
J. Eddleston,
R. Endacott,
P. Ferdinande,
H. Flaatten,
B. Guidet,
...
R. Kuhlen,
C. León-Gil,
M. C. M. Delgado,
P. Metnitz,
M. Soares,
C. Sprung,
J. Timsit,
A. Valentin
|
7 |
2012 |
7 🐜
|
🐜
|
Economic Impact of Candida Colonization and Candida Infection in the Critically Ill Patient
8 auth.
P. Olaechea,
M. Palomar,
C. León-Gil,
F. Álvarez-lerma,
R. Jordá,
J. Nolla-Salas,
...
M. A. León-Regidor,
the French Study Group
|
7 |
2004 |
7 🐜
|
🐜
|
Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin
11 auth.
A. Torres,
T. Bauer,
C. León-Gil,
F. J. Castillo,
F. Álvarez-lerma,
A. Martínez-Pellus,
...
S. Leal-Noval,
P. Nadal,
M. Palomar,
J. Blanquer,
F. Ros
|
5 |
2000 |
5 🐜
|
🐜
|
[Pandemic influenza A in the ICU: experience in Spain and Latin America. GETGAG/SEMICYUC/(Spanish Working Group on Severe Pandemic Influenza A/SEMICYUC)].
18 auth.
A. Rodríguez,
L. Socias,
J. Guerrero,
J. Figueira,
N. González,
E. Maraví-Poma,
L. Lorente,
M. Martín,
A. Albaya-Moreno,
A. Algora-Weber,
...
J. Vallés,
C. León-Gil,
T. Lisboa,
C. Balasini,
M. Villabon,
R. Perez-Padilla,
D. Barahona,
J. Rello
|
4 |
2010 |
4 🐜
|
🦁
|
Efficacy and safety of caspofungin in critically ill patients. ProCAS Study.
10 auth.
C. León-Gil,
A. Úbeda-Iglesias,
Ana Loza-Vázquez,
M. V. de la Torre,
Juan M. Raurich-Puigdevall,
B. Álvarez-Sánchez,
...
C. Ortiz-Leyva,
J. Domínguez-Roldán,
L. Socías-Crespi,
J. Garnacho-Montero
|
2 |
2012 |
2 🦁
|
🦁
|
Efficacy and safety of caspofungin in critically ill patients
11 auth.
C. León-Gil,
A. Úbeda-Iglesias,
Ana Loza-Vázquez,
M. Torre,
Juan M. Raurich-Puigdevall,
B. Álvarez-Sánchez,
...
C. Ortiz-Leyva,
-. JoséMaríaDomínguez,
Roldán,
L. Socías-Crespi,
J. Garnacho-Montero
|
2 |
2012 |
2 🦁
|
🐢
|
Intraocular candidiasis in candidemic patients
S. Donahue,
V. Yu,
J. Nolla-Salas,
C. León-Gil
|
1 |
1997 |
1 🐢
|
🐢
|
In reply to “Variables associated with survival free of severe neurological sequelae in patients recovered from cardiac arrest”
A. Loza-Vázquez,
D. Macias-Guerrero,
C. León-Gil
|
0 |
2021 |
0 🐢
|